An advisory panel on vaccines meets, carefully, in the shadow of a health secretary who has often criticized it.

Novavax (NVAX) closed the most recent trading day at $6.39, moving -0.31% from the previous trading session. This move lagged the S&P 500's daily loss of 0.17%. Meanwhile, the Dow experienced a drop ...

As in previous studies, the SHIELD study found health care workers who received the Novavax vaccine reported significantly ...

Sanofi’s next-generation experimental asthma drug failed to significantly reduce flare-ups in patients with ...

Novavax (NVAX) announced preliminary results from the SHIELD-Utah study that showed Novavax’s COVID-19 Vaccine, Adjuvanted 2024-2025 Formula ...

Mass firings at the U.S. Food and Drug Administration are particularly risky for small- and mid-cap biotech companies that ...

Shares in US biotech Novavax fell more than 20% before the weekend, following remarks from health and human services ...

After the gutting of the Department of Health and Human Services, fears mount about the future direction of the FDA—with ...

The former top vaccines official at the Food and Drug Administration criticized Health and Human Services Secretary Robert F.

Trump warned of coming pharma tariffs following an historic roller-coaster day for stocks in which the 90-day pause sparked a nearly 8% gain for the Dow Jones Industrial Average, which finished the ...

The health secretary has chipped away at the idea that immunizing children against measles and other diseases is a public health good.